EDX Medical Group Plc (AQU:EDX)

Market Cap	39.09M
Revenue	n/a
Net Income	n/a
Shares Out	372.31M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	10.50
Day's Range	n/a
52-Week Range	6.00 - 14.75
Beta	1.35
RSI	27.39
Earnings Date	n/a

About Accolade

EDX Medical Group Plc engages in developing a range of diagnostics testing solutions in the United Kingdom. It engages in the development of tests for diabetes, obesity, inflammatory disorders, and kidney and liver disorders. The company was formerly known as TECC Capital PLC and changed its name to EDX Medical Group Plc in November 2022. EDX Medical Group Plc was incorporated in 2021 and is based in Cambridge, the United Kingdom.

• Industry: Medical Laboratories
• Founded: 2021
• Country: United Kingdom
• Stock Exchange: Aquis Exchange
• Ticker Symbol: EDX